New drug 'functionally cures' many hepatitis B virus infections
Summary
A new drug has shown the ability to 'functionally cure' many hepatitis B virus infections, offering hope for a significant breakthrough in treating this chronic disease.
Similar Articles
Supercharging Immune Cells May Help Control HIV Long-Term
Early clinical trial results show that repurposing CAR-T cell therapy, originally used for cancer, can help control HIV long-term. Two patients achieved undetectable HIV levels after a single infusion and stopped medications, suggesting a potential functional cure.
Uncovering repurposed medicines to fight liver fibrosis
DeepMind's Co-Scientist AI helped identify two repurposed medicines that block liver fibrosis in lab tests, including a cancer drug that blocked 91% of a damage response, outperforming human expert selections.
Single dose of New Limit's cellular reprogramming therapy improves survival in alcohol liver damage mouse models over multiple months of repeated alcohol cycles
New Limit's cellular reprogramming therapy, delivered via mRNA in lipid nanoparticles, restores liver resilience and improves survival in aged mice subjected to repeated alcohol cycles, with human trials planned next year in Australia.
Genetically engineered hookworms can now secrete human therapeutic antibodies directly into their host's circulation, offering a potential single-dose, years-long drug delivery platform
Researchers have genetically engineered hookworms to secrete human therapeutic antibodies directly into the host's bloodstream, demonstrating a potential single-dose, long-term drug delivery platform using parasitic nematodes as biofactories.
@itsolelehmann: Demis Hassabis says he can cure every disease in 10 years. Most people roll their eyes when they hear this, but I don't…
Demis Hassabis claims AI can cure all diseases within 10 years, backed by a $2.1B funding round for Isomorphic Labs to accelerate AI-driven drug discovery and personalized medicine.